Topical treatment with benzyl benzoate and crotamiton may be an effective treatment for rosacea and demodicosis, indirectly supporting a key role of the mite in the pathophysiology of rosacea.
This review gives insight into the role of gut microbiome alterations in the pathogenesis of psoriasis, acne, rosacea, hidradenitis suppurativa, and atopic dermatitis.
Treatment options and concerns unique to patients with skin of color are reviewed.
Effects on self-perception and emotional, social, and overall well-being were significantly greater in patients with severe erythema of rosacea.
Updated recommendations include discussing disease burden with patients during consultations, and having complete clearance as the primary treatment objective.
Superficial needle-scraping can be a useful alternative or addition to standardized skin surface biopsy for evaluation of Demodex-associated facial papulopustular eruptions.
FMX103 is a topical foam formulation of the antibiotic minocycline.
Vasoconstrictors oxymetazoline and brimonidine achieve significant success in improving erythema in patients with rosacea.
Vascular endothelial growth factor may be a new target for future rosacea treatment.
One, not two, is the optimum when it comes to MFU-V with visualization treatment for rosacea.
